Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome

NCT06226402 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Nebulization
Hypertonic Saline
Acute Respiratory Distress Syndrome

Interventions

DRUG: Hypertonic saline 3% nebulizer
DRUG: Intravenous hypertonic saline 3%

Sponsor

Tanta University